Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04812743 · ClinicalTrials.gov registry record · NA
Colorectal Health Research Champions
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 91
- Enrollment target
NCT04812743: Clinical Trial NA study, sponsored by Virginia Commonwealth University.
NCT04812743 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 91 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04812743, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of the Colorectal Health Research Champions program is to provide accurate and reliable colorectal health cancer information that they can share within their communities to encourage cancer prevention, screening, and early detection, as well as the importance of participating in research.
Primary Outcome
Participant knowledge will be measured using pre/post questionnaires, with each correct answer being worth one point (14 total points) Higher summary scores indicate a greater change in knowledge. Intentions are measured on a 5 -point likert scale.
Interventions
- BEHAVIORAL Colorectal Health Research Champions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2023-05-15 |
| Phase | NA |
Why NCT04812743 stopped before completion
NCT04812743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Colorectal Health Research Champions is the first listed.
NCT04812743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04812743 about?
NCT04812743 is a clinical study titled "Colorectal Health Research Champions". The purpose of the Colorectal Health Research Champions program is to provide accurate and reliable colorectal health cancer information that they can share within their communities to encourage cancer prevention, screening, and early detection, as well as the importance of participating in research...
What is the current status of trial NCT04812743?
This trial is currently terminated. It is a NA study. The enrollment target is 91 participants. The study started on 2020-01-10. Estimated completion is 2023-05-15.
What interventions are being tested in trial NCT04812743?
The interventions under investigation include: Colorectal Health Research Champions (BEHAVIORAL).
Who is sponsoring clinical trial NCT04812743?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04812743's enrollment target sits among peer trials
91 939th of 2000 higher than 1,060 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI